SOUTH AMERICA – Pfizer and the Uruguayan government were given a 48-hour deadline by a Uruguayan judge on Monday to supply detailed information pertaining to the pharmaceutical giant’s COVID-19 vaccine while the court weighs the possibility of granting an injunction that would suspend the use of the vaccine in the South American country for children ages 5 and up.
Administrative Litigation Tribunal Judge Alejandro Recarey demanded that Pfizer – along with the Uruguayan Ministry of Public Health, State Health Services Administration, and the President’s Office – submit documentation to the court by Wednesday, yesterday, that not only details any and all contracts for Pfizer COVID-19 vaccine purchases by the country, but also the exact components of the vaccine itself.
Among the unusual information demanded by Recarey included whether or not Pfizer’s vaccine includes “nanotechnological elements,” toxic substances such as “graphene oxide,” or if it contains “messenger RNA” (which it does).
According to the American Chemical Society, Lipid nanoparticles are a component of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines.
Throughout Recarey’s documentation, he repeatedly referred to Pfizer’s products as “so-called vaccines.”
Recarey also asked for information on potential side effects, types and sizes of various doses, and effectiveness – both in adults and children – of what he repeatedly referred to as “so-called vaccines,” in addition to whether or not “the manufacturer and/or supplier, or any academic or governmental body” has “admitted” the “experimental nature of the aforementioned vaccines.”
The judge also requested data explaining “the notorious increase in deaths due to COVID-19 as of March 2021 in relation to the previous year,” the status of the vaccine’s approval by the Food and Drug Administration, and any legal protections that Pfizer and the Uruguayan government may have in-place in their contracts that would protect them in the face of adverse reactions to the jab.
Representatives from the Uruguayan government and Pfizer were set to appear at a hearing yesterday, Wednesday with the requested data; further reporting will be done on the matter as more information from the hearing comes to light.